Last update:

Gastroenterology news

Repurposed cancer drugs may help repair gut barrier in Crohn's disease

University of Houston biologists have contributed to a potential breakthrough in treating Crohn's disease by shifting the clinical focus from symptom management to addressing a primary underlying cause of the condition. Crohn's ...

Yellow food coloring changes gut microbiome in early life

A food coloring widely used in the U.S. and worldwide has been found to alter the balance of bacteria living in the gut and may cause low levels of inflammation. Researchers will present these findings at the 2026 American ...

New cellular target prevents hepatitis E infection

An international team of researchers has identified a promising new approach for treating infections with the Hepatitis E virus (HEV). At the center of the study is the drug Apilimod, which specifically blocks the entry of ...

Rectal cancer is striking earlier and killing faster

Rectal cancer deaths among older millennials are accelerating, with growth in mortality far outpacing colon cancer, suggesting primary care doctors should fully investigate early symptoms in patients under age 45, according ...

Secret to a healthy liver found in a young microbiome

Restoring the gut microbiome to its youthful state may hold the key to slowing aging and preventing liver cancer, one of the fastest-growing cancers worldwide, according to a study to be presented at Digestive Disease Week ...

Five health conditions mothers can develop after giving birth

During pregnancy, a mother's body undergoes vast structural and functional changes. But what many might not know is that the after-effects of these changes can last long after giving birth—and can even result in the development ...

How the internal liver clock orchestrates daily fat secretion

Every day, the liver packages fat and releases it into the bloodstream to fuel the body, supplying energy to the heart, muscles, and other organs during the active hours of the day. The liver does not release fat into the ...

How immune cell networks drive liver disease

A type of rare T cell triggers a cascade of signals amplifying inflammation and ultimately leading to liver fibrosis, according to a new study from Julius Maximilian University of Würzburg published in Nature Communications. ...